Chen S H, Han Q D
Institute of Vascular Medicine, Third Hospital, Beijing Medical University, China.
Zhongguo Yao Li Xue Bao. 1995 Mar;16(2):149-52.
To investigate the pathophysiological role of platelet neuropeptide Y (NPY) in hypertension.
The content of NPY in plasma and platelets from spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKR) were measured by radioimmunoassay.
There was no difference in NPY concentration between SHR plasma and WKR plasma (2.1 +/- 1.0 vs 1.8 + 1.0 microgram.L-1), but higher amounts of NPY in SHR platelets than in WKR platelets (32 +/- 6 vs 22 +/- 9 micrograms.L-1, P < 0.05). The platelet aggregation and the release of NPY from platelets induced by thrombin and collagen were increased in SHR; ADP did not cause NPY release from platelets, although it produced severe aggregation in both SHR and WKR.
The content of NPY in platelets and thrombin- and collagen-induced NPY release from platelets are higher in SHR than in WKR.
研究血小板神经肽Y(NPY)在高血压发病机制中的作用。
采用放射免疫分析法测定自发性高血压大鼠(SHR)和Wistar - Kyoto大鼠(WKR)血浆及血小板中NPY的含量。
SHR血浆和WKR血浆中NPY浓度无差异(2.1±1.0对1.8 + 1.0微克·升-1),但SHR血小板中NPY含量高于WKR血小板(32±6对22±9微克·升-1,P<0.05)。SHR中凝血酶和胶原诱导的血小板聚集及血小板NPY释放增加;ADP虽在SHR和WKR中均引起严重聚集,但不引起血小板NPY释放。
SHR血小板中NPY含量以及凝血酶和胶原诱导的血小板NPY释放均高于WKR。